Albert Despot

Prof. Dr. Albert Despot


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2026 in Antioxidants
Verified
Journal Article
Open access
PDF file
ADAlbert Despot
Albert Despot
RFRajko Fureš
Rajko Fureš
ADAna Marija Despot
Ana Marija Despot
ZHZlatko Hrgović
Zlatko Hrgović
MGMartin Gredičak
Martin Gredičak
Ivan SabolIvan Sabol
Ivan Sabol
Cervical cancer (CC) is a complex, multistep process involving various viral, molecular, cellular, endogenous, and environmental events that transform normal cervical epithelium into a malignant tumor through a cascade of events. The contribution of high-risk human papillomavirus (HPV) to cancer is significant but involves many additional mechanisms such as oxidative stress (OS), arrested apoptosis of non-functional intraepithelial neoplastic cells, senescence-associated secretory phenotype (SASP), and the final epithelial–mesenchymal transition (EMT) of cervical epithelial neoplasia (CIN) cells. While high-risk HPV oncoproteins E6 and E7 are widely recognized as the primary triggers of CC, the critical role of E6 in degrading the p53 regulatory protein, thereby inhibiting the apoptosis of reactive oxygen species (ROS)-damaged neoplastic cells, is frequently underappreciated in the gynecological literature. Arrested apoptosis of non-functional neoplastic intraepithelial cells is a key event in cervical carcinogenesis and the biological basis of CIN progression via SASP senescence and ultimately EMT. While recent reviews touched upon each of the reviewed aspects, this review aims to provide a general understanding of all links in this complex molecular-biological chain, from HPV infection, oxidative stress, arrested apoptosis, SASP, and EMT. Beyond providing an encompassing primer for clinical researchers, we additionally review potential oxidative stress-related markers for shifting the classic diagnostic and therapeutic paradigms of CIN and cervical cancer.

27 October 2026 in Cells
Verified
Journal Article
Open access
PDF file
ADAlbert Despot
Albert Despot
Ivan SabolIvan Sabol
Ivan Sabol
ZHZlatko Hrgović
Zlatko Hrgović
ADAna Marija Despot
Ana Marija Despot
IVIvica Vlatkovic
Ivica Vlatkovic
RFRajko Fureš
Rajko Fureš
Cervical cancer and breast cancer represent two serious challenges in modern gynecological oncology. Despite their anatomical accessibility for screening, significant investments in research, and the development of therapeutic strategies, their global incidence and mortality rates continue to rise. Interstitial spaces, paracrine signaling, hormonal imbalance linked to xenoestrogens (XE) and the consequent inhibition of apoptosis constitute a common, yet unfortunately insufficiently recognized, link in the carcinogenesis of both cervical and breast cancer. The aim of this paper is to supplement the classical paradigm of cervical and breast carcinogenesis by incorporating a broader context currently missing from the understanding of both forms of cancer. XEs are widely distributed chemical substances, found in a wide range of everyday products, food and environment, that mimic the action of endogenous estrogen. In the world of basic science, the connection between estrogen dominance and apoptosis avoidance is unquestionable and can undeniably impact progression of breast and cervical cancer. In the development of breast cancer, the association between XE facilitated estrogen dominance and arrested apoptosis is of great importance. In the pathogenesis of cervical cancer, the activity of viral oncogenes E6/E7 is the main driver of the pathological condition; however, in the context of arrested apoptosis, there is an area of overlap between estrogen dominance and HPV virus action. In this sense, estrogen dominance, triggered by the agonistic action of XEs on the membrane-bound GPER receptor of fibroblasts, is a cofactor in cervical carcinogenesis that remains insufficiently researched.